Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial

MLA

Matsuyuki Doi, et al. “Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Parallel-Group, Phase IIb/III Trial.” Journal of Anesthesia, vol. 34, no. 4, Nov. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42b10af7f345342593ce80cb4b98b7f9&authtype=sso&custid=ns315887.

APA

Matsuyuki Doi, Toshiyasu Suzuki, Kiyoshi Morita, Atsuhiro Sakamoto, Michiaki Yamakage, & Junzo Takeda. (2019). Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. Journal of Anesthesia, 34(4).

Chicago

Matsuyuki Doi, Toshiyasu Suzuki, Kiyoshi Morita, Atsuhiro Sakamoto, Michiaki Yamakage, and Junzo Takeda. 2019. “Efficacy and Safety of Remimazolam versus Propofol for General Anesthesia: A Multicenter, Single-Blind, Randomized, Parallel-Group, Phase IIb/III Trial.” Journal of Anesthesia 34 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....42b10af7f345342593ce80cb4b98b7f9&authtype=sso&custid=ns315887.